Delivery Order SPE2DB20D7059-SPE2DB25FPXY2
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,826.50 Firm Fixed Price Delivery Order is for the supply of 4,566,601,352 units of the drug Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of December 4, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,992.90 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The award is not designated with a set-aside requirement, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,780.06 Firm Fixed Price Delivery Order contract is for the supply of 4566844175 Mesalamine DR 1.2 GM Tablet 120S, with a performance period ending on January 7, 2025.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.78 firm fixed-price delivery order contract is for the supply of Mesalamine delayed-release tablets (1.2 gram, 120 count), with a completion date of January 20, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.96 firm fixed price delivery order is for the supply of 120 capsules of Mesalamine ER 0.375 gram, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of October 24, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award, valued at $1,351.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a specialty medication, with a completion date of May 10, 2023. This award is not designated with a set-aside requirement, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The federal contract award SPE2DB24D3013|SPE2DB25FFHSB was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order valued at $3,750.34 with a firm fixed price pricing type. The contract is for MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, and has a completion date of January 6, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,379.36 Firm Fixed Price Delivery Order, which does not have a set-aside designation, is for the supply of 180 tablets of 800 mg Delayed Release Mesalamine, a medication used to treat certain gastrointestinal conditions.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,489.66 firm fixed price delivery order is for the provision of 4564179728 - MESALAMINE DR 1.2 GM TABLET 120S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB21FP94W, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,014.37 Firm Fixed Price contract is for the delivery of 4554657830 - MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The contract has an ultimate completion date of September 7, 2021 and was awarded on September 3, 2021. There was no set-aside designation used for this...